1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Mental Health Company Analysis, July 2019

Mental Health Company Analysis, July 2019

Customer Support

Talk to Ahmad

+1 718 618 4302

data types

  • All
    • Company Data
1-30 of about 600 reports

Insulin Like Growth Factor II - Pipeline Review, H1 2019

Insulin Like Growth Factor II - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • June 2019

Insulin Like Growth Factor II - Pipeline Review, H1 2019SummaryInsulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) pipeline Target constitutes close to 8 molecules. Out ...

  • Industries : Therapy, Mental Health, Pathology, Pharmaceutical
  • Countries : World, United States
Sphingosine 1-Phosphate Receptor 1 - Pipeline Review, H1 2019

Sphingosine 1-Phosphate Receptor 1 - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • June 2019

Sphingosine 1-Phosphate Receptor 1 - Pipeline Review, H1 2019SummarySphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States, World
Metabotropic Glutamate Receptor 3 - Pipeline Review, H1 2019

Metabotropic Glutamate Receptor 3 - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • June 2019

Metabotropic Glutamate Receptor 3 - Pipeline Review, H1 2019SummaryMetabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) pipeline Target constitutes close to 9 molecules. Out of which approximately ...

  • Industries : Mental Health, Therapy, Pathology, Pharmaceutical
  • Countries : World
Insulin Like Growth Factor I - Pipeline Review, H1 2019

Insulin Like Growth Factor I - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • June 2019

Insulin Like Growth Factor I - Pipeline Review, H1 2019SummaryAccording to the recently published report ’Insulin Like Growth Factor I - Pipeline Review, H1 2019’; Insulin Like Growth Factor I (Mechano ...

  • Industries : Therapy, Mental Health, Pathology, Pharmaceutical
  • Countries : World, United States
Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A - Pipeline Review, H1 2019

Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • June 2019

Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A - Pipeline Review, H1 2019SummaryDual Specificity Tyrosine Phosphorylation Regulated Kinase 1A (Serine/Threonine Kinase MNB or MNB/DYRK Protein ...

  • Industries : Pathology, Mental Health, Therapy, Chronic Disease
  • Countries : United States
Metabotropic Glutamate Receptor 5 - Pipeline Review, H1 2019

Metabotropic Glutamate Receptor 5 - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • May 2019

Metabotropic Glutamate Receptor 5 - Pipeline Review, H1 2019SummaryMetabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) pipeline Target constitutes close to 23 molecules. Out of which approximately ...

  • Industries : Mental Health, Pathology
  • Countries : United States, World
Metabotropic Glutamate Receptor 2 - Pipeline Review, H1 2019

Metabotropic Glutamate Receptor 2 - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • May 2019

Metabotropic Glutamate Receptor 2 - Pipeline Review, H1 2019SummaryMetabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Metabotropic glutamate receptor 2 is a protein encoded by the GRM2 gene. ...

  • Industries : Mental Health, Pathology, Therapy
  • Countries : World, United States
Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) - Pipeline Review, H1 2019

Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) - Pipeline Review, H1 2019SummaryAlpha Synuclein (Non A Beta Component Of AD Amyloid or Non ...

  • Industries : Mental Health, Pathology, Therapy
  • Countries : United States
Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2019

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2019SummaryNeuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Neuronal acetylcholine receptor subunit alpha-7 is a ...

  • Industries : Mental Health, Pathology, Pharmaceutical, Therapy
  • Countries : United States, World
Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) - Pipeline Review, H1 2019

Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) - Pipeline Review, H1 ...

  • Industries : Therapy, Mental Health, Pathology, Pharmaceutical
  • Countries : United States
Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H1 2019

Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H1 2019SummaryAccording to the recently published report ’Survival Motor Neuron Protein - Pipeline Review, ...

  • Industries : Therapy, Pharmaceutical, Mental Health
  • Countries : United States, World
Alzheimer’s Disease - Pipeline Review, H1 2019

Alzheimer’s Disease - Pipeline Review, H1 2019

  • $ 2500
  • Company report
  • April 2019

Alzheimer’s Disease - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Alzheimer’s Disease - Pipeline Review, H1 2019, provides an ...

  • Industries : Therapy, Pharmaceutical
Mild Cognitive Impairment - Pipeline Review, H1 2019

Mild Cognitive Impairment - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • May 2019

Mild Cognitive Impairment - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Mild Cognitive Impairment - Pipeline Review, H1 2019, provides ...

  • Industries : Mental Health, Pathology, Therapy
  • Countries : United States
Depression - Pipeline Review, H1 2019

Depression - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • May 2019

Depression - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Depression - Pipeline Review, H1 2019, provides an overview of the Depression ...

  • Industries : Mental Health, Pathology, Pharmaceutical, Therapy
  • Countries : United States
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2019

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Attention Deficit Hyperactivity Disorde ...

  • Industries : Mental Health, Pathology, Pharmaceutical, Therapy
  • Countries : United States
Diabetic Peripheral Neuropathy - Pipeline Review, H1 2019

Diabetic Peripheral Neuropathy - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Diabetic Peripheral Neuropathy - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Peripheral Neuropathy - Pipeline Review, H1 ...

  • Industries : Pathology, Mental Health, Therapy, Pharmaceutical
  • Countries : United States
Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2019

Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 ...

  • Industries : Mental Health, Pathology
  • Countries : United States
Epilepsy - Pipeline Review, H1 2019

Epilepsy - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Epilepsy - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Epilepsy - Pipeline Review, H1 2019, provides an overview of the Epilepsy ...

  • Industries : Therapy, Mental Health, Pharmaceutical, Pathology
Drug Addiction - Pipeline Review, H1 2019

Drug Addiction - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Drug Addiction - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2019, provides an overview of ...

  • Industries : Mental Health, Pathology, Therapy, Pharmaceutical
  • Countries : United States
Autism - Pipeline Review, H1 2019

Autism - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Autism - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Autism - Pipeline Review, H1 2019, provides an overview of the Autism (Central ...

  • Industries : Mental Health, Pathology, Health Services, Healthcare, Pharmaceutical, Therapy
  • Countries : United States
Down Syndrome - Pipeline Review, H1 2019

Down Syndrome - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Down Syndrome - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Down Syndrome - Pipeline Review, H1 2019, provides an overview of the ...

  • Industries : Therapy, Mental Health, Pathology, Pharmaceutical
  • Countries : United States
Traumatic Brain Injury - Pipeline Review, H1 2019

Traumatic Brain Injury - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Traumatic Brain Injury - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Traumatic Brain Injury - Pipeline Review, H1 2019, provides ...

  • Industries : Pathology, Mental Health
  • Countries : United States
Fabry Disease - Pipeline Review, H1 2019

Fabry Disease - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • March 2019

Fabry Disease - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Fabry Disease - Pipeline Review, H1 2019, provides an overview of the ...

  • Industries : Therapy, Pathology, Pharmaceutical, Medical Biotechnology, Healthcare
  • Countries : United States
Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2019

Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • March 2019

Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2019SummaryIntegrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha o ...

  • Industries : Therapy, Pathology, Medical Biotechnology, Pharmaceutical, Biopharmaceutical, Biopharmaceutical, Oncology
  • Countries : World, United States
P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Pipeline Review, H1 2019

P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • March 2019

P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Pipeline Review, H1 2019SummaryP2X Purinoceptor 7 (P2Z Receptor or P2RX7) - P2X purinoceptor 7 is a protein encoded by the P2RX7 gene. It acts as receptor fo ...

  • Industries : Pharmaceutical, Therapy, Pathology
  • Countries : World
Becker Muscular Dystrophy - Pipeline Review, H1 2019

Becker Muscular Dystrophy - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • March 2019

Becker Muscular Dystrophy - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Becker Muscular Dystrophy - Pipeline Review, H1 2019, provides ...

  • Industries : Therapy, Mental Health, Pathology, Pharmaceutical
  • Countries : United States, World
Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Pipeline Review, H1 2019

Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • March 2019

Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Pipeline Review, H1 2019SummarySodium And Chloride Dependent Glycine Transporter 1 (Glyt1 o ...

  • Industries : Mental Health
  • Countries : World
Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2019

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • March 2019

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Peripheral Neuropathy ...

  • Industries : Therapy, Pathology, Mental Health, Oncology, Pharmaceutical
  • Countries : United States
Duchenne Muscular Dystrophy - Pipeline Review, H1 2019

Duchenne Muscular Dystrophy - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • March 2019

Duchenne Muscular Dystrophy - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Duchenne Muscular Dystrophy - Pipeline Review, H1 2019, ...

  • Industries : Pathology, Mental Health, Therapy, Pharmaceutical
  • Countries : United States
Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H1 2019

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • March 2019

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H1 2019SummaryMetabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Metabotropic glutamate receptor 4 is a protein ...

  • Industries : Mental Health, Therapy, Pathology, Pharmaceutical
  • Countries : Switzerland, World, United States

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on